A study of the safety and efficacy of rhGAA in patients with
infantile-onset
Pompe disease
Expanded Access Use of Myozyme (alglucosidase alfa) in Patients with
Late-onset
Pompe disease
Expanded access use of Myozyme (alglucosidase alfa) in patients with
infantile-onset
Pompe disease
A Prospective, Observational Study in Patients with
Late-Onset
Pompe Disease